Tyrosine kinase receptors in oncology
J Esteban-Villarrubia, JJ Soto-Castillo, J Pozas… - International journal of …, 2020 - mdpi.com
Tyrosine kinase receptors (TKR) comprise more than 60 molecules that play an essential
role in the molecular pathways, leading to cell survival and differentiation. Consequently …
role in the molecular pathways, leading to cell survival and differentiation. Consequently …
[HTML][HTML] Optimizing mutation and fusion detection in NSCLC by sequential DNA and RNA sequencing
D Cohen, LM Hondelink, N Solleveld-Westerink… - Journal of Thoracic …, 2020 - Elsevier
Introduction Frequently, patients with locally advanced or metastatic NSCLC are screened
for mutations and fusions. In most laboratories, molecular workup includes a multitude of …
for mutations and fusions. In most laboratories, molecular workup includes a multitude of …
Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1. 4
Tumor-derived exosomes (TEXs) contain enriched miRNAs that act as novel non-invasive
biomarkers for cancer diagnosis and play a role in cancer progression. We investigated the …
biomarkers for cancer diagnosis and play a role in cancer progression. We investigated the …
Randomized phase III study of pemetrexed plus cisplatin versus vinorelbine plus cisplatin for completely resected stage II to IIIA nonsquamous non–small-cell lung …
H Kenmotsu, N Yamamoto, T Yamanaka… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE To evaluate the efficacy of pemetrexed plus cisplatin versus vinorelbine plus
cisplatin as postoperative adjuvant chemotherapy in patients with pathologic stage II-IIIA …
cisplatin as postoperative adjuvant chemotherapy in patients with pathologic stage II-IIIA …
Oncogene-addicted non-small-cell lung cancer: treatment opportunities and future perspectives
MG Ferrara, V Di Noia, E D'Argento, E Vita, P Damiano… - Cancers, 2020 - mdpi.com
Before the introduction of tyrosine kinase inhibitors (TKIs) for a particular subgroup of
patients, despite platinum-based combination chemotherapy, the majority of patients …
patients, despite platinum-based combination chemotherapy, the majority of patients …
ALK inhibitors for non-small cell lung cancer: A systematic review and network meta-analysis
Background We sought to assess the relative effects of individual anaplastic lymphoma
kinase (ALK) inhibitors for the treatment of non-small cell lung cancer (NSCLC). Methods We …
kinase (ALK) inhibitors for the treatment of non-small cell lung cancer (NSCLC). Methods We …
Enabling precision oncology through precision diagnostics
NA Brown… - Annual Review of …, 2020 - annualreviews.org
Genomic testing enables clinical management to be tailored to individual cancer patients
based on the molecular alterations present within cancer cells. Genomic sequencing results …
based on the molecular alterations present within cancer cells. Genomic sequencing results …
[HTML][HTML] Conquering lung cancer: current status and prospects for the future
R Pirker - Pulmonology, 2020 - Elsevier
Lung cancer is a major global health problem. Several strategies are required to conquer
this cancer. Stricter implementations of tobacco control measures are necessary. Early …
this cancer. Stricter implementations of tobacco control measures are necessary. Early …
[HTML][HTML] Intergenic breakpoints identified by DNA sequencing confound targetable kinase fusion detection in NSCLC
W Li, Y Liu, W Li, L Chen, J Ying - Journal of Thoracic Oncology, 2020 - Elsevier
Introduction Next-generation sequencing (NGS) based on genomic DNA has been widely
applied for gene rearrangement detection in patients with NSCLC. However, intergenic …
applied for gene rearrangement detection in patients with NSCLC. However, intergenic …
A comprehensive review of clinical cardiotoxicity incidence of FDA-approved small-molecule kinase inhibitors
Y Jin, Z Xu, H Yan, Q He, X Yang, P Luo - Frontiers in Pharmacology, 2020 - frontiersin.org
Numerous protein kinases encoded in the genome have become attractive targets for the
treatment of different types of cancer. As of January 2020, a total of 52 small-molecule …
treatment of different types of cancer. As of January 2020, a total of 52 small-molecule …